Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174 | 995 | 0 | 1 | 13 |
| Receivables | N/A | N/A | N/A | 1 | N/A |
| Inventories | N/A | N/A | 1 | N/A | N/A |
| TOTAL | $174 | $999 | $1 | $2 | $48 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 0 | 37 | 47 |
| Intangibles | 0 | 0 | 65 | 193 | 207 |
| Other Non-Current Assets | 4 | 4 | 0 | 0 | 0 |
| TOTAL | $4 | $4 | $65 | $230 | $254 |
| Total Assets | $177 | $1,003 | $65 | $232 | $302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18 | 0 | 0 | 0 | 745 |
| Accrued Expenses | 38 | N/A | 18 | N/A | 81 |
| TOTAL | $57 | $300 | $34 | $N/A | $1,946 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,500 | 69 | 0 | 2,112 | 0 |
| TOTAL | $6,500 | $69 | $N/A | $2,112 | $N/A |
| Total Liabilities | $6,557 | $369 | $34 | $2,112 | $1,946 |
| Shareholders' Equity | |||||
| Common Shares | 211 | 166 | 0 | 55 | 55 |
| Retained earnings | -11,323 | -316 | -23 | -30,550 | -30,314 |
| Other shareholders' equity | 0 | -350 | 0 | 0 | 0 |
| TOTAL | $-6,379 | $633 | $31 | $-1,880 | $-1,644 |
| Total Liabilities And Equity | $177 | $1,003 | $65 | $232 | $302 |